Copyright: ©Author(s) 2026.
World J Orthop. Jul 18, 2026; 17(7): 120800
Published online Jul 18, 2026. doi: 10.5312/wjo.120800
Published online Jul 18, 2026. doi: 10.5312/wjo.120800
Table 1 Representative intervention strategies targeting intervertebral disc degeneration and aging
| Classification | Medicine | Effect | Signal pathway | Evidence type | Ref. |
| Anti-oxidative stress and mitochondrial protection | Curcumin | Anti-inflammatory; reduces oxidative damage; mitochondrial protection | MAPK | Cell; animal | [49-51] |
| Resveratrol | Modulates mitochondrial function, ROS generation, and cellular energy metabolism; prevents loss of ΔΨm; preserves intracellular ATP; reduces OS-induced apoptosis; promotes matrix biosynthesis | PI3K/Akt | Cell | [52-55] | |
| Naringin | Anti-apoptotic; mitochondrial protection | PI3K/Akt | Cell | [57,58] | |
| Epigallocatechin-3-gallate | Protects ΔΨm; promote cell survival | Cell | [59] | ||
| Kinsenoside | Inhibits NP cell senescence and mitochondrial dysfunction; enhances antioxidant capacity | AKT-ERK1/2-Nrf2 | Cell; animal | [60] | |
| Apigenin | Protects NP cells from senescence | Cell | [61] | ||
| HSP70 | Alleviates oxidative stress-induced senescence in NP cells | JNK/c-Jun | Cell | [63] | |
| PGA-Mn-TP04 | Restores mitochondrial function by modulating mitochondrial dynamics; improves NP cell survival; preserves disc height and NP hydration | Cell; animal | [64] | ||
| Honokiol | Suppresses apoptosis-related proteins, oxidative stress markers, inflammatory mediators, and ECM-degrading enzymes; promotes ECM anabolic protein expression | NF-κB/JNK | Cell | [65] | |
| Redox modulators and mitochondria-targeted antioxidants | PQQ, fullerene, fullerol | Reduce ROS-related damage; protect disc cells from oxidative injury; fullerol promotes matrix synthesis | Cell; animal | [67-72] | |
| Glutathione | Reduce ROS | Cell | [69] | ||
| Estrogen | Alleviates IVDD partly by modulating antioxidant enzymes and autophagy-related pathways | Animal | [73,74] | ||
| MitoQ | Regulate mitochondrial dynamics | Nrf2 | Cell; Animal | [75] | |
| MitoTEMPO | Mitigates mitochondrial ROS accumulation, inflammatory activation, and mitochondrial dysfunction | Cell | [26] | ||
| SkQ1 | Anti-apoptotic; restores ΔΨm and reduces ROS levels | Cell | [77] | ||
| XJB-5-131 | Restore disc structure | Animal | [78] | ||
| Mitophagy regulation | Urolithin A | Promote mitophagy | AMPK | Cell; animal | [83] |
| Anti-inflammatory therapy | Higenamine | Inhibition of NF-κB pathway activation and aging of NP cells | NF-κB | Cell | [94] |
| Omentin-1 | Alleviate NP cell senescence, reduce G1 phase cell cycle arrest, and enhance ECM synthesis | Cell | [95] | ||
| Dehydrocostus lactone | Reduce inflammation and ECM degradation | NF-κB; MAPK; STING-TBK1/NF-κB | Cell; animal | [96] | |
| Senolytic therapy | O-vanillin | Reduces senescent cell burden and improves matrix synthesis | Human disc cells/tissues | [101] | |
| Dasatinib + quercetin | Remove senescent cells | Animal | [99,100] |
- Citation: Wang ZP, Zhang HW, Zhao XY, Li YZ, Zhang XG, Zhao R, Qin DP. Intervertebral disc degeneration and aging: Shared molecular mechanisms and therapeutic interventions. World J Orthop 2026; 17(7): 120800
- URL: https://www.wjgnet.com/2218-5836/full/v17/i7/120800.htm
- DOI: https://dx.doi.org/10.5312/wjo.120800